Content is intended for people aged >18 years only
Allergan Medical Institute™
Our Allergan Medical Institute provides an empowering, comprehensive and progressive learning journey for all injector capability levels, delivered through our expert multi-disciplinary team of Faculty clinicians who bring their skills and market knowledge to the AMI programme.
A variety of training programs are offered to support our customers to pursue the highest levels of clinical excellence and patient experience to deliver the best outcome; hands-on trainings, roundtable forums, national symposia, live webcast events, exclusive resources, and an online learning continuum.
Allergan Medical Institute by Allergan Aesthetics is an educational website that contains promotional materials available to healthcare professionals only. Allergan supports training of appropriately qualified healthcare professionals. We define this as individuals who hold a recognised and valid Medical Doctor, Dental Surgery or Human Nursing qualification, allowing them to practice independently as a Doctor, Dentist or Nurse in the UK.
Allergan SPARK
We created the Spark to help the next generation of aesthetics professionals thrive. Making the transition into medical aesthetics is challenging and it can be hard to find the right support. We want to create the destination for aesthetics professionals to receive holistic, relevant and trusted support wherever they are in their aesthetics journey.
Spark by Allergan Aesthetics is an educational website that contains promotional materials available to healthcare professionals only. Allergan supports training of appropriately qualified healthcare professionals. We define this as individuals who hold a recognised and valid Medical Doctor, Dental Surgery or Human Nursing qualification, allowing them to practice independently as a Doctor, Dentist or Nurse in the UK.
Adverse events should be reported. UK reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available at Google Play or Apple App stores.
Irish healthcare professionals (HCPs) are asked to report any suspected adverse reactions via HPRA Pharmacovigilance; website https://www.hpra.ie. Adverse events should also be reported to AbbVie on ProductSurveillance_EAME@allergan.com.
UK-AGNA-230233 Date of Preparation:- June 2024